Lasers in Medical Science· 2026Q2
577-nm Diyot Lazer Koyu Tenli Hastalarda Piyoojenik Granülomu Etkin Bir Şekilde Tedavi Etti
Treatment of pyogenic granuloma with a 577-nm diode laser in dark-skinned patients: A prospective case series
- 0atıf
- Q2SCImago
- 2026yıl
Kısa özet
577-nm diyot lazer, koyu tenli (IV-V cilt tipleri) hastalarda piyoojenik granülomlarda %89 (9 hastadan 8'inde) tam iyileşme sağladı ve çoğu hastada sadece 1-2 tedavi seansı gerektirdi.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Ana noktalar
- 577-nm diyot lazer, IV-V cilt tiplerine sahip 9 hastada piyoojenik granülomları tedavi etmek için kullanıldı.
- Tüm hastalarda tam iyileşme sağlandı ve 7 hasta sadece 1-2 tedavi seansı gerektirdi.
- Lazer tedavi protokolü iki haftada bir seansları içeriyordu.
- Atrofik skar, tek bildirilmiş yan etkiydi ve bir hastada görüldü.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Özet (abstract)
Pyogenic granulomas are common benign vascular lesions found on exposed skin in children. Treatment in darker skin types can be challenging because of increased epidermal melanin absorption and the associated risk of collateral thermal injury. To evaluate the efficacy and safety of a 577-nm diode laser for the treatment of pyogenic granuloma in patients with dark skin types. Nine patients with pyogenic granuloma and skin types IV-V were enrolled in this prospective case series. They were treated every two weeks with a 577 nm diode laser using a 1 mm spot size, with fluence ranging from 19–23 J/cm2 depending on lesion size until bleeding stopped. Sessions were repeated every two weeks until complete clearance. Patients were followed clinically and photographically every two weeks, and then one month after the final session. This prospective case series included 9 patients clinically diagnosed with pyogenic granuloma. The mean age was 18.0 ± 14.6 years (range, 6-40 years), and the mean duration of pyogenic granuloma was 9.1 ± 3.94 months. Lesions were present on the lips of 4 patients (44.4%), the cheeks in 2 patients (22.2%), hands (2 patients, 22.2%), and neck (1 patient, 11.1%). All patients were treated with a 577 nm diode laser session every 2 weeks until complete clearance. Complete clearance was achieved in 3 patients after the first session, 4 patients after the second session, 1 patient after third session, and only one patient required four treatment sessions. Atrophic scarring was the only reported side effect, occurring in one case. Treatment with a 577-nm diode laser appears to be a safe and effective option for pyogenic granuloma in patients with darker skin types.
Yazarların özeti; kaynağından alınmıştır. Lasers in Medical Science, 2026 · DOI ↗
Ücretsiz hesapla devam et
Makaleye Sor ile bu makaleye günde 3 soru ücretsiz; makaleyi kaydet, kaynakçasını al, ilgi alanına göre her gün yeni özetler. Çıkarımlar Premium.
Web'de ücretsiz devam etGoogle ya da Apple hesabınla giriş; kart istemez. Bu makaleye geri dönersin.
Telefonda:
Alan: Dermatoloji
DermatologyMedicine